(Q34543969)

English

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

0 references

0 references

Christopher R Chapple

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

P Araño

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

J L H R Bosch

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

A E J L Kramer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

A M Ridder

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

93

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

71-77

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04561.X

21 January 2018

The overactive bladder: prevalence and effects on quality of life

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04561.X

21 January 2018

Muscarinic receptor antagonists in the treatment of overactive bladder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04561.X

21 January 2018

M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04561.X

21 January 2018

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04561.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2004.04561.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678372%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34543969&oldid=1638696163"